Evidence map›Paper›PMID 26876875›Full record

ReviewActa biomaterialia2016

Stepping into the omics era: Opportunities and challenges for biomaterials science and engineering.

Nathalie Groen, Murat Guvendiren, Herschel Rabitz, William J Welsh, Joachim Kohn, Jan de Boer

Abstract readReview
In one paragraph

Review in Acta biomaterialia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Materiobiology in the omics era.Materials today. Bio · 2025
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Mapping Biomaterial Complexity by Machine Learning.Tissue engineering. Part A · 2024
    Review
  8. Review
  9. Article
  10. Harnessing Biomaterials for Immunomodulatory-Driven Tissue Engineering.Regenerative engineering and translational medicine · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Threats to adhesive/dentin interfacial integrity and next generation bio-enabled multifunctional adhesives.Journal of biomedical materials research. Part B, Applied biomaterials · 2019
    Review
  17. The Human Ovary and Future of Fertility Assessment in the Post-Genome Era.International journal of molecular sciences · 2019
    Review
  18. Article
  19. Progress in three-dimensional printing with growth factors.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Review
  20. Tissue-informed engineering strategies for modeling human pulmonary diseases.American journal of physiology. Lung cellular and molecular physiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nathalie Groen *Department of Tissue Regeneration, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands.
Murat Guvendiren *New Jersey Center for Biomaterials, Rutgers University, Piscataway, NJ, USA.
Herschel RabitzDepartment of Chemistry, Princeton University, Princeton, NJ, USA.
William J WelshDepartment of Pharmacology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, USA.
Joachim KohnNew Jersey Center for Biomaterials, Rutgers University, Piscataway, NJ, USA.
Jan de BoerDepartment of Tissue Regeneration, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands.

Funding

RESBIO - the Technology Resource for Polymeric BiomaterialsP41EB001046 · NIBIB · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI KOHN, JOACHIM B. · 2003 to 2017
$17.0M
NIBIB NIH HHS P41 EB001046
6 · The paper itself

Abstract

The research paradigm in biomaterials science and engineering is evolving from using low-throughput and iterative experimental designs towards high-throughput experimental designs for materials optimization and the evaluation of materials properties. Computational science plays an important role in this transition. With the emergence of the omics approach in the biomaterials field, referred to as materiomics, high-throughput approaches hold the promise of tackling the complexity of materials and understanding correlations between material properties and their effects on complex biological systems. The intrinsic complexity of biological systems is an important factor that is often oversimplified when characterizing biological responses to materials and establishing property-activity relationships. Indeed, in vitro tests designed to predict in vivo performance of a given biomaterial are largely lacking as we are not able to capture the biological complexity of whole tissues in an in vitro model. In this opinion paper, we explain how we reached our opinion that converging genomics and materiomics into a new field would enable a significant acceleration of the development of new and improved medical devices. The use of computational modeling to correlate high-throughput gene expression profiling with high throughput combinatorial material design strategies would add power to the analysis of biological effects induced by material properties. We believe that this extra layer of complexity on top of high-throughput material experimentation is necessary to tackle the biological complexity and further advance the biomaterials field. STATEMENT OF SIGNIFICANCE: In this opinion paper, we postulate that converging genomics and materiomics into a new field would enable a significant acceleration of the development of new and improved medical devices. The use of computational modeling to correlate high-throughput gene expression profiling with high throughput combinatorial material design strategies would add power to the analysis of biological effects induced by material properties. We believe that this extra layer of complexity on top of high-throughput material experimentation is necessary to tackle the biological complexity and further advance the biomaterials field.

Indexed as

AnimalsBiocompatible MaterialsCombinatorial Chemistry TechniquesGenomicsHumansMaterials TestingBiocompatible MaterialsCombinatorial screeningComputational modelingConverging omics fieldsGenomicsHigh-throughput experimentationMateriomicsTranscriptomics

Identifiers

PMID26876875
PMCPMC4830461

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.